BOCA RATON, FL -- (MARKET WIRE) -- October 30, 2006 -- Vicor Technologies, Inc., developer of the Vicor PD2i Cardiac Analyzer, a patented risk stratification device for Sudden Cardiac Death (SCD), today announced that David H. Fater, President and Chief Executive Officer, will present an overview of the Company, including Vicor's proprietary device, the initiation of a key 510(k) trial and commercialization strategy, at the Rodman & Renshaw Eighth Annual Healthcare Conference.
